News related to Atripla (Efavirenz / Emtricitabine / Tenofovir) and/or conditions it is approved for
No new HIV infections in large pre-exposure prophylaxis study
Source: Sexual Health / STDs News From Medical News Today [2015.09.03]
An observational study evaluating the use of pre-exposure prophylaxis found that no new cases of HIV infection occurred during an assessment period of 32 months.
Targeting semen proteins to prevent HIV infection
Source: Sexual Health / STDs News From Medical News Today [2015.08.18]
Researchers describe two approaches they say could prevent HIV infection by targeting proteins in semen called amyloid fibrils that boost transmission of the virus.
International team discovers natural defense against HIV
Source: HIV / AIDS News From Medical News Today [2015.09.17]
Researchers at Michigan State University were part of a team to discover a new natural defense against HIV infection.
Why do certain hormonal contraceptives increase the risk of HIV?
Source: Sexual Health / STDs News From Medical News Today [2015.09.02]
In recent years, evidence has been building that injectable contraceptive depot medroxyprogesterone acetate (Depo-Provera or DMPA) is associated with an increased risk of HIV infection.